tradingkey.logo

Sanara Medtech Inc

SMTI
25.040USD
+0.830+3.43%
收盤 12/22, 16:00美東報價延遲15分鐘
223.63M總市值
虧損本益比TTM

Sanara Medtech Inc

25.040
+0.830+3.43%

關於 Sanara Medtech Inc 公司

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Inc簡介

公司代碼SMTI
公司名稱Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)
員工數量141
證券類型Ordinary Share
年結日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編76102
電話18175292300
網址https://sanaramedtech.com/
公司代碼SMTI
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)

Sanara Medtech Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
業務USD
名稱
營收
佔比
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%

股東統計

更新時間: 12月5日 週五
更新時間: 12月5日 週五
持股股東
股東類型
持股股東
持股股東
佔比
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
其他
36.61%
持股股東
持股股東
佔比
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
其他
36.61%
股東類型
持股股東
佔比
Corporation
45.04%
Individual Investor
20.27%
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.42%
Research Firm
0.98%
Hedge Fund
0.78%
Bank and Trust
0.11%
Pension Fund
0.11%
其他
21.85%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
109
1.11M
12.48%
-19.18K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
FA Sanara, L.L.C.
3.51M
39.45%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.86%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.76%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.51%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
175.98K
1.98%
-20.48K
-10.43%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
187.10K
2.1%
-6.12K
-3.17%
Jun 30, 2025
Stonebridge Wealth Management, LLC
119.66K
1.34%
+19.60K
+19.59%
Jun 30, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
77.74K
0.87%
-11.01K
-12.41%
Jun 30, 2025
Marshall Wace LLP
71.51K
0.8%
+42.24K
+144.28%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
查看更多
Texas Capital Texas Small Cap Equity Index ETF
佔比0.05%
WisdomTree US SmallCap Fund
佔比0.03%
iShares Micro-Cap ETF
佔比0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Global X Russell 2000 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Sanara Medtech Inc的前五大股東是誰?

Sanara Medtech Inc的前五大股東如下:
FA Sanara, L.L.C.
持有股份:3.51M
佔總股份比例:39.45%。
Stuckert (James W)
持有股份:966.97K
佔總股份比例:10.86%。
Tall Pines Capital LLC
持有股份:512.87K
佔總股份比例:5.76%。
Howell (Solomon Oden Jr)
持有股份:490.39K
佔總股份比例:5.51%。
The Vanguard Group, Inc.
持有股份:175.98K
佔總股份比例:1.98%。

Sanara Medtech Inc的前三大股東類型是什麼?

Sanara Medtech Inc 的前三大股東類型分別是:
FA Sanara, L.L.C.
Stuckert (James W)
Tall Pines Capital LLC

有多少機構持有Sanara Medtech Inc(SMTI)的股份?

截至2025Q3,共有109家機構持有Sanara Medtech Inc的股份,合計持有的股份價值約為1.11M,占公司總股份的12.48% 。與2025Q2相比,機構持股有所增加,增幅為-64.28%。

哪個業務部門對Sanara Medtech Inc的收入貢獻最大?

在FY2025Q2,Soft tissue repair products業務部門對Sanara Medtech Inc的收入貢獻最大,創收22.66M,占總收入的87.73% 。
KeyAI